A detailed history of Rhumbline Advisers transactions in Davita Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 152,674 shares of DVA stock, worth $24.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
152,674
Previous 157,743 3.21%
Holding current value
$24.5 Million
Previous $21.9 Million 14.5%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$133.98 - $165.19 $679,144 - $837,348
-5,069 Reduced 3.21%
152,674 $25 Million
Q2 2024

Aug 01, 2024

BUY
$126.11 - $147.14 $19.9 Million - $23.2 Million
157,743 New
157,743 $21.9 Million
Q1 2024

May 09, 2024

BUY
$103.89 - $139.21 $2.07 Million - $2.77 Million
19,892 Added 13.92%
162,807 $22.5 Million
Q4 2023

Feb 08, 2024

SELL
$73.2 - $108.8 $914,121 - $1.36 Million
-12,488 Reduced 8.04%
142,915 $15 Million
Q3 2023

Nov 09, 2023

SELL
$94.53 - $112.68 $63,051 - $75,157
-667 Reduced 0.43%
155,403 $14.7 Million
Q2 2023

Aug 08, 2023

SELL
$81.58 - $100.93 $289,445 - $358,099
-3,548 Reduced 2.22%
156,070 $15.7 Million
Q1 2023

May 11, 2023

BUY
$74.68 - $85.82 $1.89 Million - $2.17 Million
25,338 Added 18.87%
159,618 $12.9 Million
Q4 2022

Feb 14, 2023

BUY
$65.42 - $99.31 $575,630 - $873,828
8,799 Added 7.01%
134,280 $10 Million
Q3 2022

Nov 10, 2022

SELL
$80.24 - $95.27 $109,126 - $129,567
-1,360 Reduced 1.07%
125,481 $10.4 Million
Q2 2022

Aug 11, 2022

SELL
$76.05 - $123.38 $1.77 Million - $2.88 Million
-23,326 Reduced 15.53%
126,841 $10.1 Million
Q1 2022

May 12, 2022

BUY
$108.37 - $120.0 $376,477 - $416,880
3,474 Added 2.37%
150,167 $17 Million
Q4 2021

Feb 10, 2022

SELL
$94.5 - $116.95 $255,433 - $316,115
-2,703 Reduced 1.81%
146,693 $16.7 Million
Q3 2021

Nov 12, 2021

BUY
$116.26 - $133.78 $1.15 Million - $1.32 Million
9,884 Added 7.08%
149,396 $17.4 Million
Q2 2021

Aug 05, 2021

SELL
$105.44 - $127.98 $824,540 - $1 Million
-7,820 Reduced 5.31%
139,512 $16.8 Million
Q1 2021

May 06, 2021

SELL
$99.98 - $123.89 $153,269 - $189,923
-1,533 Reduced 1.03%
147,332 $15.9 Million
Q4 2020

Feb 10, 2021

SELL
$82.82 - $117.4 $2.26 Million - $3.2 Million
-27,272 Reduced 15.48%
148,865 $17.5 Million
Q3 2020

Nov 12, 2020

SELL
$79.57 - $91.84 $153,013 - $176,608
-1,923 Reduced 1.08%
176,137 $15.1 Million
Q2 2020

Aug 13, 2020

SELL
$65.52 - $88.28 $750,531 - $1.01 Million
-11,455 Reduced 6.04%
178,060 $14.1 Million
Q1 2020

May 06, 2020

BUY
$64.99 - $88.5 $826,282 - $1.13 Million
12,714 Added 7.19%
189,515 $14.4 Million
Q4 2019

Feb 05, 2020

SELL
$54.2 - $75.03 $645,955 - $894,207
-11,918 Reduced 6.32%
176,801 $13.3 Million
Q3 2019

Oct 23, 2019

SELL
$52.55 - $63.28 $1.85 Million - $2.23 Million
-35,166 Reduced 15.71%
188,719 $10.8 Million
Q2 2019

Aug 14, 2019

SELL
$43.42 - $57.79 $2.38 Million - $3.16 Million
-54,708 Reduced 19.64%
223,885 $12.6 Million
Q1 2019

May 01, 2019

SELL
$49.95 - $59.21 $454,545 - $538,811
-9,100 Reduced 3.16%
278,593 $15.1 Million
Q4 2018

Jan 31, 2019

SELL
$48.73 - $76.08 $54,431 - $84,981
-1,117 Reduced 0.39%
287,693 $14.8 Million
Q3 2018

Nov 07, 2018

SELL
$66.51 - $74.55 $1.45 Million - $1.63 Million
-21,805 Reduced 7.02%
288,810 $20.7 Million
Q2 2018

Aug 06, 2018

SELL
$62.77 - $73.47 $396,769 - $464,403
-6,321 Reduced 1.99%
310,615 $21.6 Million
Q1 2018

May 02, 2018

SELL
$65.0 - $80.03 $537,810 - $662,168
-8,274 Reduced 2.54%
316,936 $20.9 Million
Q4 2017

Feb 09, 2018

BUY
$53.89 - $72.36 $218,523 - $293,419
4,055 Added 1.26%
325,210 $23.5 Million
Q3 2017

Nov 06, 2017

BUY
$56.13 - $64.78 $18 Million - $20.8 Million
321,155
321,155 $19.1 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $14.6B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.